Pure Global
NCT05062408

Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals

Impact of the Sustained Viral Response on the Natural History Chronic Hepatitis c After Treatment With Direct Action Antivirals
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hepatitis C, Chronic
Study type
Observational
Sponsor & location
Primary sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Location
Sevilla, Spain
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2021
End date
Apr 01, 2021
Enrollment
321 participants
Primary outcome

Number of patients with a progression of liver injury.

Summary

The purpose of this study is to evaluate the evolution of liver injury with fibrosis data
 obtained using non-invasive serological markers in patients who achieved SVR after treatment
 with direct-acting antivirals.

ICD-10 classifications
Chronic viral hepatitis CAcute hepatitis CChronic hepatitis, unspecifiedChronic viral hepatitisChronic viral hepatitis, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05062408
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05062408 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación Pública Andaluza para la gestión de la Investigación en Sevilla and is currently Completed. The study focuses on Hepatitis C, Chronic. Target enrollment is 321 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.